Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eike Burandt
Correction: Genomic Deletion of Chromosome 12p Is an Independent Prognostic Marker in Prostate Cancer
Oncotarget
Oncology
PSCA Expression Is Associated With Favorable Tumor Features and Reduced PSA Recurrence in Operated Prostate Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer
Oncology Letters
Cancer Research
Oncology
Ribosomal Protein L19 Is a Prognostic Marker for Human Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
NADiA ProsVue Prostate-Specific Antigen Slope Is an Independent Prognostic Marker for Identifying Men at Reduced Risk of Clinical Recurrence of Prostate Cancer After Radical Prostatectomy
Urology
Urology
Prostate Cancer Genomic Signature Offers Prognostic Value
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
CD24 Is Expressed in Ovarian Cancer and Is a New Independent Prognostic Marker of Patient Survival
American Journal of Pathology
Forensic Medicine
Pathology
Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer
PLoS ONE
Multidisciplinary
Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients
Contrast Media and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Maximum Tumor Diameter Is an Independent Predictor of Prostate-Specific Antigen Recurrence in Prostate Cancer
Modern Pathology
Forensic Medicine
Pathology
miR‑320a Is an Independent Prognostic Biomarker for Invasive Breast Cancer
Oncology Letters
Cancer Research
Oncology
